product

29 articles in this category (Page 2 of 2)

guidanceearningsproduct

Amazon.com, Inc. (AMZN) - 2026-02-27 - Sideways - Confidence: 6

Despite accelerating AWS growth and a new OpenAI partnership, Amazon's massive $200B AI CapEx plan is dragging down free cash flow, leading to near-term price consolidation.

Feb 27, 2026AMZN

ManagementProductFinancials

TSLA 21-Day Outlook: Decrease Expected Amid Executive Departure and Margin Compression

Deteriorating margins and the departure of a key Cybercab executive signal a likely downward correction for Tesla's overvalued shares.

Feb 27, 2026TSLA

EarningsProductMacro

ACM Research (ACMR): Strong 2026 Guidance and Singapore Expansion Signal Upside Despite Valuation Headwinds

Fresh 2026 revenue guidance of up to $1.175B and a breakthrough delivery to a Singapore foundry provide a strong bullish catalyst for ACMR.

Feb 26, 2026ACMR

managementearningsproduct

Tesla (TSLA) Faces Mixed Signals Amid Falling Deliveries and High Valuation: Sideways Outlook

Despite analyst upgrades, Tesla's declining deliveries and massive 14% gap between gross and net margins suggest a sideways consolidation phase.

Feb 24, 2026TSLA

regulatoryproductearnings

ImmunityBio (IBRX) 21-Day Outlook: Increase Expected Amidst Global ANKTIVA Approvals Despite Overbought Technicals

ImmunityBio's massive 700% revenue growth and new international ANKTIVA approvals signal upside potential, though overbought technicals and deep negative margins cap confidence.

Feb 23, 2026IBRX